Evidence for involvement of the complement system in AAV comes from murine models of MPO-ANCA-induced glomerulonephritis and vasculitis, demonstrating activation of the alternative complement pathway and specifically C5 being essential for disease induction (84, 85). The gene discussed is MPO; the disease is glomerulonephritis.